Registry of patients undergoing coronary interventions at Hanyang University hospitals
HanYang University Medical Center (HYUMC) PCI Registry
Hanyang University Seoul Hospital · NCT05935397
This study is collecting information from patients with coronary artery disease who have had heart procedures to see how they do over time and what factors might affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Hanyang University Seoul Hospital (other) |
| Locations | 3 sites (Guri and 2 other locations) |
| Trial ID | NCT05935397 on ClinicalTrials.gov |
What this trial studies
The HYUMC registry is a two-center observational registry that collects data on patients with coronary artery disease who have undergone percutaneous coronary intervention (PCI) at Hanyang University Seoul and Guri Hospitals since January 2012. It aims to evaluate long-term clinical outcomes and identify predictors of adverse outcomes following PCI. Researchers gather demographic, laboratory, echocardiographic, and angiographic data, along with patient questionnaires, to assess the impact of these factors on patient health over time.
Who should consider this trial
Good fit: Ideal candidates include patients with coronary artery disease who have undergone PCI with drug-eluting stents at the participating hospitals.
Not a fit: Patients who have had multiple hospital admissions, died during hospitalization, or were treated with first-generation drug-eluting stents may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of long-term outcomes for patients with coronary artery disease, leading to improved treatment strategies.
How similar studies have performed: Other observational registries have shown success in identifying long-term outcomes in similar patient populations, suggesting that this approach is validated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea. Exclusion Criteria: * second or subsequent hospitalization records of patients with multiple admissions * patients who died during index hospitalization * patients who treated with first-generation drug eluting stent * patients with an outpatient follow-up record of less than 6 months * patients with insufficient medical records.
Where this trial is running
Guri and 2 other locations
- Hanyang University Guri Hospital — Guri, Korea, Republic of (RECRUITING)
- Hanyang University Seoul Hospital — Seoul, Korea, Republic of (RECRUITING)
- Young-Hyo Lim — Seoul, Korea, Republic of (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Coronary Artery Stenosis, Coronary Artery Disease, Blood Pressure